Kaposi's sarcoma differential diagnosis: Difference between revisions

Jump to navigation Jump to search
No edit summary
Line 13: Line 13:
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Etiology
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Congenital
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquied
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Acquired
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Demography
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="7" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Clinical manifestations
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! colspan="6" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Lab findings
! colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! colspan="1" rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Gold standard diagnosis
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Additional findings
! rowspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Associated findings
|-
|-
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
! colspan="3" style="background: #4479BA; color: #FFFFFF; text-align: center;" |Symptoms
Line 40: Line 40:
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Bacillary angiomatosis]] <ref name="pmid7553576">{{cite journal |vauthors=Tappero JW, Perkins BA, Wenger JD, Berger TG |title=Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus |journal=Clin. Microbiol. Rev. |volume=8 |issue=3 |pages=440–50 |date=July 1995 |pmid=7553576 |pmc=174635 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="left" |  
| style="background:#F5F5F5;" align="left" |  
* HIV
* [[Human Immunodeficiency Virus (HIV)|HIV]]
* Chronic lymphocytic leukemia
* [[Chronic lymphocytic leukemia]]
* Cytotoxic chemotherapy
* Cytotoxic [[chemotherapy]]
* Organ transplantation
* [[Organ transplant|Organ transplantation]]
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-50 years
| style="background:#F5F5F5;" align="center" | Any age, usually between 20 -50 years
| style="background:#F5F5F5;" align="center" | Solitary or multiple red, purple, flesh-colored, or colorless papules
| style="background:#F5F5F5;" align="center" | Solitary or multiple red, purple, flesh-colored, or colorless [[Papule|papules]]
| style="background:#F5F5F5;" align="center" | +/-
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | +/-
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Anorexia,
* [[Anorexia]]
* Weight loss
* [[Weight loss]]
* Abdominal pain  
* [[Abdominal pain]]
* Nausea, and vomiting
* [[Nausea and vomiting]]
* Headache
* [[Headache]]
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 64: Line 64:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Lobular vascular proliferations of vessels lined by plump endothelial cells
| style="background:#F5F5F5;" align="center" |
* Lobular vascular proliferations of [[Blood vessel|vessels]] lined by plump [[Endothelium|endothelial cells]]
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="center" | Clinical manifestation
| style="background:#F5F5F5;" align="center" |  
| style="background:#F5F5F5;" align="center" |  
*Psychiatric disorders  
*[[Mental disorder|Psychiatric disorders]]
*Personality changes
*[[Personality|Personality changes]]
*Seizure
*[[Seizure]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Arteriovenous malformation]] <ref name="pmid23125071">{{cite journal |vauthors=Whitehead KJ, Smith MC, Li DY |title=Arteriovenous malformations and other vascular malformation syndromes |journal=Cold Spring Harb Perspect Med |volume=3 |issue=2 |pages=a006635 |date=February 2013 |pmid=23125071 |pmc=3552339 |doi=10.1101/cshperspect.a006635 |url=}}</ref>
| style="background:#F5F5F5;" align="left" |Idiopathic
| style="background:#F5F5F5;" align="left" |
* [[Idiopathic]]
 
*
*
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Any age
| style="background:#F5F5F5;" align="center" | Any age
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Headache
* [[Headache]]
* Neurologic deficits
* [[Neurologic diseases|Neurologic deficits]]
* Heart failure
* [[Congestive heart failure|Heart failure]]
* Macrocephaly
* [[Macrocephaly]]
| style="background:#F5F5F5;" align="center" |Nl
| style="background:#F5F5F5;" align="center" |Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 93: Line 96:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | N/A
| style="background:#F5F5F5;" align="center" |NA
| style="background:#F5F5F5;" align="center" | Imaging
| style="background:#F5F5F5;" align="center" | [[Imaging]]
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Hereditary hemorrhagic telangiectasia
* [[Hereditary hemorrhagic telangiectasia]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Acroangiodermatitis <ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Acroangiodermatitis]]<ref name="pmid17868541">{{cite journal |vauthors=Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A |title=Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports |journal=Acta Dermatovenerol Croat |volume=15 |issue=3 |pages=152–7 |date=2007 |pmid=17868541 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="center" | Idioathic
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
* [[Idiopathic]]
| style="background:#F5F5F5;" align="center" | -
* Hyperplasia of pre-existing vasculature
| style="background:#F5F5F5;" align="center" | More frequent in male, any ages
* [[Hypertension|HTN]]
| style="background:#F5F5F5;" align="center" | Purplish-blue to brown papules and plaques
 
| style="background:#F5F5F5;" align="center" | -
*
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Any age, more in males
| style="background:#F5F5F5;" align="center" | Purplish-blue to brown [[Papule|papules]] and [[Plaque|plaques]]
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
* Paralysed legs
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 115: Line 124:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" |Hyperkeratosis, parakeratosis, acanthosis, and mild spongiosis
| style="background:#F5F5F5;" align="center" |
* [[Hyperkeratosis]]
* Parakeratosis
* [[Acanthosis nigricans|Acanthosis]]
* Mild spongiosis
| style="background:#F5F5F5;" align="center" | Clinical manifesttations
| style="background:#F5F5F5;" align="center" | Clinical manifesttations
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Amputees,
* [[Amputation]]
* Haemodialysis (HD) patients with arteriovenous (AV) shunts
* [[Hemodialysis|Haemodialysis]] patients with [[Arteriovenous fistula|arteriovenous shunts]]
* Paralysed legs
* [[Hepatitis C]]
* Hepatitis C
* [[Venous insufficiency|Chronic venous insufficiency]]
* Chronic venous insufficiency  
* [[Arteriovenous malformation|AV malformations]]
* AV malformations
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" | [[Angiosarcoma]] <ref name="pmid2734404">{{cite journal |vauthors=Barttelbort SW, Stahl R, Ariyan S |title=Cutaneous angiosarcoma of the face and scalp |journal=Plast. Reconstr. Surg. |volume=84 |issue=1 |pages=55–9 |date=July 1989 |pmid=2734404 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="center" | Idiopathic
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
* [[Idiopathic]]
| style="background:#F5F5F5;" align="center" | -
 
| style="background:#F5F5F5;" align="center" | More frequent in males, usually in adults
*
| style="background:#F5F5F5;" align="center" |Enlarging bruise, a blue-black nodule, or an unhealed ulceration
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" | Adults, more in males
| style="background:#F5F5F5;" align="center" |Enlarging [[bruise]], a blue-black [[Nodule (medicine)|nodule]], or an unhealed [[Ulcer|ulceration]]
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | ↓
| style="background:#F5F5F5;" align="center" | ↓
Line 143: Line 158:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Intercellular and intracellular lumina with or without red cells
* Intercellular and intracellular lumina with or without [[Red blood cell|red cells]]
* Intermediate filaments and pinocytotic vesiclesin cytoplasm
* Intermediate filaments and pinocytotic vesicles in [[cytoplasm]]
* Weibel-Palade bodies
* [[Weibel-Palade body|Weibel-Palade bodies]]
| style="background:#F5F5F5;" align="center" | Biopsy
| style="background:#F5F5F5;" align="center" | [[Biopsy]]
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |NA
|-
|Diseases
|Etiology
|Congenital
|Acquired
|Demography
!Appearance
!Fever
!Bleeding
!BP
!Hepatosplenomegaly
!Lymphadenopathy
!Other
!WBC
!Hb
!Plt
|LFT
|ESR/CRP
|Histopathology
|Gold standard diagnosis
|Associated findings
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Masson's [[hemangioma]] <ref name="pmid22993679">{{cite journal |vauthors=Park KK, Won YS, Yang JY, Choi CS, Han KY |title=Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review |journal=J Korean Neurosurg Soc |volume=52 |issue=1 |pages=52–4 |date=July 2012 |pmid=22993679 |pmc=3440504 |doi=10.3340/jkns.2012.52.1.52 |url=}}</ref>
| style="background:#F5F5F5;" align="center" | Idiopathic
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
* [[Idiopathic]]
| style="background:#F5F5F5;" align="center" | -
 
| style="background:#F5F5F5;" align="center" | N/A
*
| style="background:#F5F5F5;" align="center" |  
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |Rare
| style="background:#F5F5F5;" align="center" |
* Normal
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 166: Line 206:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Papillary fronds lined by proliferating endothelium
| style="background:#F5F5F5;" align="center" | Clinical manifestations and histological findings
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* HemangiomaS
* Papillary fronds lined by proliferating [[endothelium]]
* Pyogenic granulomas
| style="background:#F5F5F5;" align="center" | [[Biopsy]]
* Lymphagiomas
| style="background:#F5F5F5;" align="center" |
* [[Hemangioma]]
* [[Pyogenic granuloma|Pyogenic granulomas]]
* [[Lymphangioma overview|Lymphangiomas]]
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Seborrheic keratosis]] <ref name="pmid18845088">{{cite journal |vauthors=Noiles K, Vender R |title=Are all seborrheic keratoses benign? Review of the typical lesion and its variants |journal=J Cutan Med Surg |volume=12 |issue=5 |pages=203–10 |date=2008 |pmid=18845088 |doi=10.2310/7750.2008.07096 |url=}}</ref>
| style="background:#F5F5F5;" align="center" | Clonal expansion of a mutated epidermal keratinocyte
| style="background:#F5F5F5;" align="center" |
* Clonal expansion of a mutated epidermal [[keratinocyte]]
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Any age
| style="background:#F5F5F5;" align="center" | Any age
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Usually asymptomatic
* Usually [[asymptomatic]]
* Being stuck on the skin surface
* Being stuck on the skin surface
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 192: Line 234:
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Papillomatous epithelial proliferation containing horn cysts
| style="background:#F5F5F5;" align="center" |
* Papillomatous epithelial proliferation containing horn [[Cyst|cysts]]
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="center" | Clinical manifestations
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Dermatosis papulosa nigra
* [[Dermatosis papulosa nigra]]
* Stucco keratosis
* Stucco keratosis
* Melanoacanthoma
* Melanoacanthoma
Line 201: Line 244:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |[[Systemic lupus erythematosus]] ([[SLE]]) <ref name="pmid22888407">{{cite journal |vauthors=Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P |title=Cutaneous manifestations of systemic lupus erythematosus |journal=Autoimmune Dis |volume=2012 |issue= |pages=834291 |date=2012 |pmid=22888407 |pmc=3410306 |doi=10.1155/2012/834291 |url=}}</ref>
| style="background:#F5F5F5;" align="center" | Idiopathic
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" | More coomon in female, typically in the 20 to 30 years
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Erythema on the nasolabial folds
* [[Idiopathic]]
* Macular or diffusely erythematous in sun-exposed areas (photosensitive rash)
 
*
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | –
| style="background:#F5F5F5;" align="center" | More common in female, typically in the 20 to 30 years
| style="background:#F5F5F5;" align="center" |
* [[Erythema]] on the [[Mouth|nasolabial folds]]
* [[Macule|Macular]] or diffusely erythematous in sun-exposed areas
* Discoid rash
* Discoid rash
| style="background:#F5F5F5;" align="center" | +/-
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" | ↑
| style="background:#F5F5F5;" align="center" | ↑
| style="background:#F5F5F5;" align="center" | +/-
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" | +/-
| style="background:#F5F5F5;" align="center" | ±
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
* Weight loss
* [[Weight loss]]


* Headache
* [[Headache]]
* Arthralgia
* [[Arthralgia]]
* Myalgia
* [[Myalgia]]
* Nausea and dyspepsia
* [[Nausea and vomiting|Nausea]]
* Pleuritic chest pain
* [[Dyspepsia]]
* Dyspnea
* [[Pleuritic chest pain]]
* Hematuria
* [[Dyspnea]]
* [[Hematuria]]
| style="background:#F5F5F5;" align="center" | ↑
| style="background:#F5F5F5;" align="center" | ↑
| style="background:#F5F5F5;" align="center" | ↓
| style="background:#F5F5F5;" align="center" | ↓
Line 256: Line 303:
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years
| style="background:#F5F5F5;" align="center" | Any age, usually in 20-30 years
| style="background:#F5F5F5;" align="center" | Painless red lesion (lobular capillary hemangioma)
| style="background:#F5F5F5;" align="center" | Painless red lesion (lobular capillary hemangioma)
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 272: Line 319:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Benign lymphangioendothelioma <ref name="pmid10935645">{{cite journal |vauthors=Guillou L, Fletcher CD |title=Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series |journal=Am. J. Surg. Pathol. |volume=24 |issue=8 |pages=1047–57 |date=August 2000 |pmid=10935645 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="center" | Idiopathic
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
* [[Idiopathic]]
 
*
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | +
| style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years  
| style="background:#F5F5F5;" align="center" | Any ages, median age is 50 years  
| style="background:#F5F5F5;" align="center" | single, slowly expanding patch, plaque, or nodule
| style="background:#F5F5F5;" align="center" | single, slowly expanding patch, plaque, or nodule
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 293: Line 343:
|-
|-
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref>
| style="background: #DCDCDC; padding: 5px; text-align: center;" |Cavernous [[hemangioma]] <ref name="pmid229814">{{cite journal |vauthors=Goldberg RE, Pheasant TR, Shields JA |title=Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement |journal=Arch. Ophthalmol. |volume=97 |issue=12 |pages=2321–4 |date=December 1979 |pmid=229814 |doi= |url=}}</ref>
| style="background:#F5F5F5;" align="center" | Idiopathic
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
* [[Idiopathic]]
| style="background:#F5F5F5;" align="center" | -
 
*
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Usually in third to fifth decades of life.
| style="background:#F5F5F5;" align="center" | Usually in third to fifth decades of life.
| style="background:#F5F5F5;" align="center" | Painless, slowly progressive protrusion or bulging of their globe
| style="background:#F5F5F5;" align="center" | Painless, slowly progressive protrusion or bulging of their globe
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | -
| style="background:#F5F5F5;" align="center" |
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
| style="background:#F5F5F5;" align="center" | Nl
Line 317: Line 370:


* Visual field deficits
* Visual field deficits
|-
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|}
|}



Revision as of 17:35, 4 October 2018


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2] Haytham Allaham, M.D. [3]

Kaposi's sarcoma Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Kaposi's sarcoma from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

Echocardiograph and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Kaposi's sarcoma differential diagnosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Kaposi's sarcoma differential diagnosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Kaposi's sarcoma differential diagnosis

CDC on Kaposi's sarcoma differential diagnosis

Kaposi's sarcoma differential diagnosis in the news

Blogs on Kaposi's sarcoma differential diagnosis

Directions to Hospitals Treating Kaposi's sarcoma

Risk calculators and risk factors for Kaposi's sarcoma differential diagnosis

Overview

Kaposi's sarcoma must be differentiated from other diseases that cause similar cutaneous, pulmonary, and gastrointestinal involvement, such as bacillary angiomatosis, AIDS-related lymphoma, and seborrheic keratosis.

Differentiating Kaposi's Sarcoma from other Diseases

Diseases Etiology Congenital Acquired Demography Clinical manifestations Lab findings Gold standard diagnosis Associated findings
Symptoms Signs CBC LFT ESR/CRP Histopathology
Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt
Bacillary angiomatosis [4] + Any age, usually between 20 -50 years Solitary or multiple red, purple, flesh-colored, or colorless papules ± ± Nl Nl Nl Nl Nl Nl Clinical manifestation
Arteriovenous malformation [5]
+ Any age Nl + Nl Nl Nl Nl Nl Nl NA Imaging
Acroangiodermatitis[6]
Any age, more in males Purplish-blue to brown papules and plaques Nl
  • Paralysed legs
Nl Nl Nl Nl Nl Clinical manifesttations
Angiosarcoma [7]
Adults, more in males Enlarging bruise, a blue-black nodule, or an unhealed ulceration Nl Nl Nl Nl Biopsy NA
Diseases Etiology Congenital Acquired Demography Appearance Fever Bleeding BP Hepatosplenomegaly Lymphadenopathy Other WBC Hb Plt LFT ESR/CRP Histopathology Gold standard diagnosis Associated findings
Masson's hemangioma [8]
Rare
  • Normal
Nl Nl Nl Nl Nl Nl Biopsy
Seborrheic keratosis [9] + Any age Nl Nl Nl Nl Nl Nl
  • Papillomatous epithelial proliferation containing horn cysts
Clinical manifestations
Systemic lupus erythematosus (SLE) [10]
More common in female, typically in the 20 to 30 years ± - ± ± - Nl
  • Hyperkeratosis, epidermal atrophy, vacuolar interface dermatitis
  • Thickening of the basement membrane
  • Superficial, perivascular, and perifollicular mononuclear cell inflammatory infiltrate
Clinical manifestations
  • Raynaud phenomenon
  • Neuropsychiatric symptoms
  • Pleural effusion
  • Peptic ulcer diseas
  • Pericarditis
  • Myocarditis
Pyogenic granuloma [11]
  • Trauma
  • Hormonal influences
  • Viruses
  • Cytogenetic clonal deletion abnormalities
+ + Any age, usually in 20-30 years Painless red lesion (lobular capillary hemangioma) + Nl Nl Nl Nl Nl Nl Neutrophilic infiltration, hemorrhage, necrosis of the overlying epidermis Clinical manifestation -
Benign lymphangioendothelioma [12]
+ Any ages, median age is 50 years single, slowly expanding patch, plaque, or nodule Nl Nl Nl Nl Nl Nl Thin-walled endothelial-lined spaces that are interspersed between strands of collagen Clinical manifestation and biopsy -
Cavernous hemangioma [13]
Usually in third to fifth decades of life. Painless, slowly progressive protrusion or bulging of their globe Nl Nl Nl Nl Nl Nl Engorged vascular channels, which are tightly knit and separated by fibrous septae Clinical manidestation
  • Diplopia
  • Decreased color vision
  • Visual field deficits

References

  1. Kaposi's Sarcoma. Radiopaedia (2015) http://radiopaedia.org/articles/kaposi-sarcoma Accessed on January, 19 2016
  2. Libre Pathology. Kaposi's sarcoma (2015) http://librepathology.org/wiki/index.php/File:Kaposi_sarcoma_low_intermed_mag.jpg Accessed on January, 19 2016
  3. Kaposi's Sarcoma. PathologyOutlines (2015) http://www.pathologyoutlines.com/topic/skintumornonmelanocytickaposisarcoma.html Accessed on January, 19 2015
  4. Tappero JW, Perkins BA, Wenger JD, Berger TG (July 1995). "Cutaneous manifestations of opportunistic infections in patients infected with human immunodeficiency virus". Clin. Microbiol. Rev. 8 (3): 440–50. PMC 174635. PMID 7553576.
  5. Whitehead KJ, Smith MC, Li DY (February 2013). "Arteriovenous malformations and other vascular malformation syndromes". Cold Spring Harb Perspect Med. 3 (2): a006635. doi:10.1101/cshperspect.a006635. PMC 3552339. PMID 23125071.
  6. Lugović L, Pusić J, Situm M, Buljan M, Bulat V, Sebetić K, Soldo-Belić A (2007). "Acroangiodermatitis (pseudo-Kaposi sarcoma): three case reports". Acta Dermatovenerol Croat. 15 (3): 152–7. PMID 17868541.
  7. Barttelbort SW, Stahl R, Ariyan S (July 1989). "Cutaneous angiosarcoma of the face and scalp". Plast. Reconstr. Surg. 84 (1): 55–9. PMID 2734404.
  8. Park KK, Won YS, Yang JY, Choi CS, Han KY (July 2012). "Intravascular Papillary Endothelial Hyperplasia (Masson tumor) of the Skull : Case Report and Literature Review". J Korean Neurosurg Soc. 52 (1): 52–4. doi:10.3340/jkns.2012.52.1.52. PMC 3440504. PMID 22993679.
  9. Noiles K, Vender R (2008). "Are all seborrheic keratoses benign? Review of the typical lesion and its variants". J Cutan Med Surg. 12 (5): 203–10. doi:10.2310/7750.2008.07096. PMID 18845088.
  10. Uva L, Miguel D, Pinheiro C, Freitas JP, Marques Gomes M, Filipe P (2012). "Cutaneous manifestations of systemic lupus erythematosus". Autoimmune Dis. 2012: 834291. doi:10.1155/2012/834291. PMC 3410306. PMID 22888407.
  11. Kamal R, Dahiya P, Puri A (January 2012). "Oral pyogenic granuloma: Various concepts of etiopathogenesis". J Oral Maxillofac Pathol. 16 (1): 79–82. doi:10.4103/0973-029X.92978. PMC 3303528. PMID 22434943.
  12. Guillou L, Fletcher CD (August 2000). "Benign lymphangioendothelioma (acquired progressive lymphangioma): a lesion not to be confused with well-differentiated angiosarcoma and patch stage Kaposi's sarcoma: clinicopathologic analysis of a series". Am. J. Surg. Pathol. 24 (8): 1047–57. PMID 10935645.
  13. Goldberg RE, Pheasant TR, Shields JA (December 1979). "Cavernous hemangioma of the retina. A four-generation pedigree with neurocutaneous manifestations and an example of bilateral retinal involvement". Arch. Ophthalmol. 97 (12): 2321–4. PMID 229814.

Template:WH Template:WS